In 2021, the Chinese pharmaceutical companies invested between 1.27 and 12.63 percent of their sales revenue in research and development. That year, Livzon Pharmaceutical Group spent around 1.5 billion yuan on R&D, accounting for 12.63 percent of its sales revenue.
Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Pharmaceuticals Holding. (March 30, 2023). Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. "Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022." Chart. March 30, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. (2023). Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. "Share of Research and Development in Sales Revenue of Selected Pharmaceutical Companies in China in 2021 and 2022." Statista, Statista Inc., 30 Mar 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding, Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/ (last visited November 10, 2024)
Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 [Graph], Shanghai Pharmaceuticals Holding, March 30, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
